Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
Go back to Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer| (NASDAQ: LXEO) | Delayed: 2.67 -0.07 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.74 | 52 Week High | $ | |||
| Open | $2.70 | 52 Week Low | $ | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.63 | EPS | $ | |||
| Volume | 360,403 | |||||



